Apoptosis of human seminoma cells upon disruption of their microenvironment

British Journal of Cancer

Volumn 73, Issue 9, 1996, Pages 1031-1036

  Olie, R A ^a,b   Boersma, A W M ^a   Dekker, M C ^a   Nooter, K ^a   Looijenga, L H J ^a   Oosterhuis, J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Ctr d'Immunol ISERM CNRS M   (France)

Author keywords

Apoptosis; bcl 2; Human seminoma; Microenvironment; p53

Indexed keywords

DNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LABELING; CELL STRUCTURE; CLINICAL ARTICLE; DNA DEGRADATION; ELECTROPHORESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SEMINOMA;

EID: 0030005979     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.200     Document Type: Article

References (64)

1. ANDREWS PW. (1984). Pluripotent embryonal carcinoma clones derived from the human teratoma cell line Tera-2: differentiation in vivo and in vitro. Lab. Invest., 50, 147-167.
2. ARAKI S, SHIMADA Y, KAJI K AND HAYASHI H. (1990). Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem. Biophys. Res. Commun., 168, 1194-1200.
3. ARENDS MJ AND WYLLIE AH. (1991). Apoptosis: mechanisms and roles on pathology. Int. Rev. Exp. Pathol., 32, 223-254.
4. BAKSHI A, JENSEN JP, GOLDMAN P, WRIGHT JJ, MCBRIDE OW, EPSTEIN AL AND KORSMEYER SJ. (1985). Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 41, 889-906.
5. BARDON S, VIGNON F, MONTCOURRIER P AND ROCHEFORT H. (1987). Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res., 47, 1441-1448.
6. BARRES BA, HART IK, COLES SR, BURNE JF, VOYVODIC JT, RICHARDSON WD AND RAFF MC. (1992). Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70, 31-46.
7. BOERSMA AWM, NOOTER K, OOSTRUM R AND STOTER G. (1995). Quantification of apoptotic cells with FITC-labelled annexin v in CHO cell cultures treated with Cis-Pt. Cytometry (In press).
8. BUTTKE TM AND SANDSTROM PA. (1994). Oxidative stress as a mediator of apoptosis. Immunol. Today, 15, 7-10.
9. CLARKE AR, PURDIE CA, HARRISON DJ, MORRIS RG, BIRD CC, HOOPER ML AND WYLLIE AH. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849.
10. CLEARY ML AND SKLAR J. (1985). Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl Acad. Sci. USA, 82, 7439-7443.
11. COLLINS MKL, PERKINS GR, RODRIGUEZ-TARDUCHY G, NIETO MA AND LOPEZ-RIVAS A. (1994). Growth factors as survival factors: Regulation of apoptosis. BioEssays, 16, 133-138.
12. DARZYNKIEWICZ Z, BRUNO S, DEL BINO G, GORCZYCA W, HOTZ MA, LASSOTA P AND TRAGANOS F. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808.
13. DEHNER LP. (1986). Gonadal and extragonadal germ cell neoplasms-teratomas in childhood. In Pathology of Neoplasia in Children and Adolescents, Boyd S (ed.), pp. 282-312, WB Sauders: Philadelphia.
14. DEHNER LP. (1990). Germ cell tumors of the mediastinum. Semin. Diagn. Pathol., 7, 266-284.
15. DOLCI S, WILLIAMS DE, ERNST MK, RESNICK JL, BRANNAN CI, LOCK LF, LYMAN SD, BOSWELL HS AND DONOVAN PJ. (1991). Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature, 352, 809-811.
16. DONEHOWER LA, HARVEY M, SLAGLE BL, MCARTHUR MJ, MONTGOMERY CA AND BUTEL JS. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
17. EIZENBERG O, FABER-ELMAN A, GOTTLIEB E, OREN M, ROTTER V AND SCHWARTZ M. (1995). Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J., 14, 1136-1144.
18. FOSSÀ SD, DROZ JP, STOTER G, KAYE SB, VERMEYLEN K AND SYLVESTER R. (1995). Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. Br. J. Cancer, 71, 619-624.
19. FRISCH SM AND FRANCIS H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell. Biol., 124, 619-626.
20. GARCIA I, MARTINOU I, TSUJIMOTO Y AND MARTINOU J-C. (1992). Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science, 258, 302-304.
21. GIANNONE L AND WOLFF SN. (1988). Recent progress in the treatment of seminoma. Oncology, 2, 21-27.
22. GODIN I, DEED R, COOKE J, ZSEBO K, DEXTER M AND WYLIE CC. (1991). Effect of the steel gene product on mouse primordial germ cells in culture. Nature, 352, 807-809.
23. GONDOS B. (1993). Ultrastructure of developing and malignant germ cells. Eur. Urol., 23, 68-75.
24. HANKS GE, PETERS T AND OWEN J. (1992). Seminoma of the testis: Long term beneficial and deleterious results of radiation. Int. J. Radiat. Oncol. Biol. Phys., 24, 9-19.
25. HINCHCLIFFE JR. (1981). Cell death in embryogenesis. In Cell Death and Biology and Pathology, Lockshin RA and Bowen ID (eds.), pp. 35-78. Chapman and Hall: New York.
26. HOCKENBERRY D, NUNEZ G, MILLIMAN C, SCHREBER RD AND KORSMEYER SJ. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-336.
27. HOLSTEIN AF. (1993). Cellular components of early testicular cancer. Eur. Urol., 23, 9-18.
28. HOLSTEIN AF, SCHUTTE B, BECKER H AND HARTMANN M. (1987). Morphology of normal and malignant germ cells. Int. J. Androl., 10, 1-18.
29. JACOBSON MD, BURNE JF, KING MP, MIYASHITA T, REED JD AND RAFF MC. (1993). Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature, 361, 365-369.
30. KERR JFR AND SEARLE J. (1973). Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch. B, 13, 87-92.
31. KERR JFR, SEARLE J, HARMON BV AND BISHOP CJ. (1987). Apoptosis. In Perspectives on Mammalian Cell Death, Potten CS (ed.), pp. 93-128, Oxford University Press: Oxford.
32. LANE DP. (1993). A death in the life of p53. Nature, 362, 786-787.
33. LOWE SW, SCHMITT EM, SMITH SW, OSBORNE BA AND JACKS T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
34. MANIATIS T, FRITSCH EF AND SAMBROOK J. (1982). Isolation of high molecular-weight, eukaryotic DNA from cells grown in tissue culture. In Molecular Cloning, p. 280, Cold Spring Harbor Laboratory Press: New York.
35. MATSUI Y, ZSEBO K AND HOGAN BL. (1992). Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell, 70, 841-847.
36. MOSTOFI FK. (1980). Pathology of germ cell tumors of testis. A progress report. Cancer, 45, 1735-1754.
37. MOSTOFI FK. (1984). Tumour markers and pathology of testicular tumours. In Progress and Controversies in Oncological Urology, pp. 69-87, Liss AR: New York.
38. MOSTOFI FK, SESTERHENN IA AND DAVIS CJJ. (1987). Immunopathology of germ cell tumors of the testis. Semin. Diagn. Pathol., 4, 320-341.
39. MURTY VVVS, HOULDSWORTH J, BALDWIN S, REUTER V, HUNZIKER W, BESMER P, BOSL G AND CHAGANTI RSK. (1992). Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proc. Natl Acad. Sci. USA, 89, 11006-11010.
40. NOOTER K, BOERSMA AWM, OOSTRUM RG, BURGER H, JOCHEMSEN AG AND STOTER G. (1995). Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. Br. J. Cancer, 71, 556-561.
41. OLIE RA, LOOIJENGA LHJ, DEKKER MC, DE JONG FH, DE ROOY DG AND OOSTERHUIS JW. (1995a). Heterogeneity in the in vitro survival and proliferation of human seminoma cells. Br. J. Cancer, 71, 13-17.
42. OLIE RA, LOOIJENGA LHJ, BOERRIGTER L, TOP B, RODENHUIS S, MULDER MP AND OOSTERHUIS JW. (1995b). N- and K-ras mutations in human testicular germ cell tumors: incidence and possible biological implications. Genes Chromosom. Cancer, 12, 110-116.
43. OOSTERHUIS JW, CASTEDO SMMJ, DE JONG B, CORNELISSE CJ, DAM A, SLEIJFER DT AND SCHRAFFORDT KOOPS H. (1989). Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab. Invest., 60, 14-20.
44. OREN M. (1992). p53: The ultimate tumor suppressor gene? FASEB J., 6, 3169-3176.
45. PESCE M AND DE FELICI M. (1994). Apoptosis in mouse primordial germ cells: A study by transmission and scanning electron microscope. Anat. Embryol., 189, 435-440.
46. PESCE M, FARRACE MG, PIACENTINI M, DOLCI S AND DE FELICI M. (1993). Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development. 118, 1089-1094.
47. RAWSON CL, LOO DT, DUIMSTRA JR, HEDSTROM OR, SCHMIDT EE AND BARNES DW. (1991). Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation. J. Cell. Biol. 113, 671-680.
48. RESNICK JL, BIXLER LS, CHENG L AND DONOVAN PJ. (1992). Long-term proliferation of mouse primordial germ cells in culture. Nature, 359, 550-551.
49. SCHLAEPFER DD, HANKS SK, HUNTER T AND VAN DER GEER P. (1994). Integrin-mediated signal transduction linked to ras pathway by GRB2 binding to focal adhesion kinase. Nature, 372, 786-791.
50. SENTMAN CL, SHUTTER JR, HOCKENBERY D, KANAGAWA O AND KORSMEYER SJ. (1991). bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888.
51. SKAKKEBÆK NE, BERTHELSEN JG, GIWERCMAN A AND MÜLLER J. (1987). Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int. J. Androl., 10, 19-28.
52. 2 phase and cell death induced by cisplatin. J. Natl Cancer Inst., 82, 749-755.
53. STROHMEYER T, PETER S, HARTMANN M, MUNEMITSU S, ACKERMANN R, ULLRICH A AND SLAMON DJ. (1991). Expression of the hst-1 and c-kit protooncogenes in human teslicular germ cell tumors. Cancer Res., 51, 1811-1816.
54. TSUJIMOTO Y, YUNIS J, ONORATO-SHOWE L, ERIKSON J, NOWELL PC AND CROCE CM. (1984). Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science, 224, 1403-1406.
55. ULBRIGHT TM AND ROTH LM. (1987). Recent development in the pathology of germ cell tumors. Semin. Diagn. Pathol., 4, 301-319.
56. VAUX DL, CORY S AND ADAMS JM. (1988). Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-442.
57. VAUX DL, HAECKER G AND STRASSER A. (1994). An evolutionary perspective on apoptosis. Cell, 76, 777-779.
58. WARING P, KOS FJ AND MUELLBACHER A. (1991). Apoptosis or programmed cell death. Med. Res. Rev., 11, 219-236.
59. WIJSMAN JH, JONKER RR, KEIJZER R, VAN DE VELDE CJH, CORNELISSE CJ AND VAN DIERENDONCK JH. (1993). A new method to detect apoptosis in paraffin sections: In situ end-labelling of fragmented DNA. J. Histochem. Cytochem., 41, 7-12.
60. WILLIAMS GT. (1991). Programmed cell death: apoptosis and oncogenesis. Cell, 65, 1097-1098.
61. WYLLIE AH. (1980). Glucocortocoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
62. WYLLIE AH, KERR JFR AND CURRIE AR. (1980). Cell death: the significance of apoptosis. Int. Rev. Cytol., 68, 251-306.
63. YONISH-ROUACH E, RESNITSKY D, LOTEM J, SACHS L, KIMCHI A AND OREN M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemia cells that is inhibited by IL6, Nature, 352, 345-347.
64. YOUNG RH, CLEMENT PB AND SCULLY RE. (1994). The ovary. In Diagnostic Surgical Pathology, pp. 2195-2280. Raven Press: New York.